TAK-041

TAK-041 · Neurocrine Biosciences

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TAK-041, covering 2019-12-23 to 2021-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study [Phase 1]